{
  "type": "hyp",
  "text": "Interestingly PGE2 or di-butyryl (Bt2)cAMP abolished the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells stimulated with anti-CD3 mAb but not with PMA/A23187.\n",
  "self": {
    "NER": {
      "answers": [
        "Bt2)cAMP",
        "mAb",
        "PMA/A23187"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the name of the di-butyryl that abolished the binding of",
          "What did cells stimulated with anti-CD3 use?",
          "What drug did not abolish the binding of NF-kappa B?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Interestingly PGE2",
        "di-butyryl",
        "Bt2)cAMP",
        "the binding",
        "(p50/p65",
        "the kappa B sequence",
        "cells"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the name of the molecule that abolished the binding of NF-k",
          "What is another name for Bt2cAMP?",
          "What is the name of the di-butyryl that abolished the binding of",
          "What did PGE2 or di-butyryl (Bt2)cAMP abolish?",
          "What is the NF-kappa B sequence?",
          "What did PGE2 or di-butyryl (Bt2)cAMP abolish the",
          "What type of cells were stimulated with anti-CD3 mAb?"
        ]
      }
    }
  },
  "asked": {
    "What is the name of the antibody that inhibits tumor necrosis?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0021772384643554688,
        "ground_truth": {
          "TNF": {
            "bertscore": 0.6789320707321167,
            "f1": 0
          },
          "(TNF-alpha": {
            "bertscore": 0.6426272392272949,
            "f1": 0
          }
        }
      }
    },
    "What was inhibited by a monoclonal antibody?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.03040289878845215,
        "ground_truth": {
          "all those early and late events": {
            "bertscore": 0.6556384563446045,
            "f1": 0
          },
          "not the immediate ones": {
            "bertscore": 0.6779466867446899,
            "f1": 0
          }
        }
      }
    },
    "What was the antibody that inhibited all early and late events of the disease?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.019195616245269775,
        "ground_truth": {
          "a neutralizing anti-tumor necrosis factor alpha": {
            "bertscore": 0.5818167328834534,
            "f1": 0
          }
        }
      }
    },
    "What inhibited all early and late events?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.010855376720428467,
        "ground_truth": {
          "monoclonal antibody": {
            "bertscore": 0.6599296927452087,
            "f1": 0
          }
        }
      }
    }
  }
}